Related Experiment Video
Updated: May 12, 2026
08:53
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1: a missing link in the Fanconi anemia/BRCA pathway
1Departments of Radiation Oncology and Pediatrics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA. alan_dandrea@dfci.harvard.edu
Cancer Discovery
|April 13, 2013
Summary
This case report highlights a woman with ovarian cancer and carboplatin hypersensitivity who had BRCA1 gene mutations. These findings reinforce BRCA1
Area of Science:
- Oncology
- Genetics
- Clinical Medicine
Background:
- Ovarian cancer is a significant health concern, with genetic predispositions playing a crucial role in its development.
- BRCA1 gene mutations are known risk factors for hereditary breast and ovarian cancers.
- Carboplatin hypersensitivity can complicate cancer treatment regimens.
Purpose of the Study:
- To report a unique case of a patient with congenital abnormalities, ovarian cancer, and carboplatin hypersensitivity.
- To investigate the genetic basis of the patient's condition, specifically focusing on BRCA1 mutations.
- To explore the implications of these findings for understanding the Fanconi anemia/BRCA pathway and genetic testing.
Main Methods:
- Case report detailing a 28-year-old woman's medical history and clinical presentation.
- Genetic analysis to identify germline mutations in BRCA1 alleles.
- Review of existing literature on BRCA1, Fanconi anemia, and carboplatin hypersensitivity.
Main Results:
- The patient presented with congenital abnormalities, inherited ovarian cancer, and carboplatin hypersensitivity.
- Validated germline mutations were identified in both BRCA1 alleles.
- The findings suggest a potential link between BRCA1 mutations and carboplatin hypersensitivity.
Conclusions:
- The case further implicates the BRCA1 gene in the Fanconi anemia/BRCA pathway.
- These findings underscore the importance of comprehensive genetic testing for individuals with a history of ovarian cancer and unexplained symptoms.
- Understanding the role of BRCA1 in this context may inform future treatment strategies and genetic counseling.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:37Restarting Stalled Replication Forks
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...